QA7-11861-50829
4 vaccinations
3 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 146 / NY
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-25
Dose 1 — Moderna
-
2021-01-20
Registered in v-safe
- 2021-01-20
-
2021-01-22
Dose 2 — Moderna
- 2021-01-22
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
-
2021-01-29
Health check-in — day 7, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-07
- 2021-02-12
- 2021-02-19
- 2021-04-23
- 2021-07-23
-
2021-11-10
Dose 3 — Moderna
-
2022-01-22
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-25
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-12
Dose 4 — Pfizer-BioNTech
- 2022-10-12
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-26
- 2022-11-04
- 2022-11-23
-
2023-01-11
Survey response — 3 months, dose 4MedDRA: Abdominal pain, Back pain, Cough, Fatigue, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-25 | Moderna | |
| 2 | 2021-01-22 | Moderna | |
| 3 | 2021-11-10 | Moderna | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-22 | Successful 2022-01-25 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Release 11 — 12 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release